The National Institutes of Health (NIH) is seeking a highly experienced, senior-level, biological therapeutics development consultant with expertise in Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC). This individual would be expected to provide guidance and advice on biologics development processes for the National Institute of Neurological Disorders and Stroke (NINDS) Ultra-Rare Gene Therapy (URGenT) program, the NIH Blueprint Neurotherapeutics (BPN) Biologics program, and other NINDS and trans-NIH programs where therapeutic oligonucleotide CMC expertise is required.